Trial: 202102193

Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: A Randomized Phase 3 Non-Inferiority Trial

Phase

III

Principal Investigator

Reimers, Melissa

Disease Site

Urinary Bladder

Learn more about this study at: clinicaltrials.gov